These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35815118)

  • 1. Impact of the Pilot Volume-Based Drug Purchasing Policy in China: Interrupted Time-Series Analysis with Controls.
    Chen Y; Ji X; Xiao H; Unger JM; Cai Y; Mao Z; Yeung K
    Front Pharmacol; 2021; 12():804237. PubMed ID: 35815118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of "4 + 7" volume-based drug procurement on the volume, expenditures, and daily costs of antihypertensive drugs in Shenzhen, China: an interrupted time series analysis.
    Yang Y; Tong R; Yin S; Mao L; Xu L; Hao S; Mao Z
    BMC Health Serv Res; 2021 Nov; 21(1):1275. PubMed ID: 34823516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of the national volume-based procurement policy on the use of policy-related drugs in Nanjing: an interrupted time-series analysis.
    Wang X; He X; Zhang P; Zhang M; Ma R; Dai R; Li X
    Int J Equity Health; 2023 Sep; 22(1):200. PubMed ID: 37770924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of China's National Volume-Based Procurement on Drug Procurement Price, Volume, and Expenditure: An Interrupted Time Series Analysis in Tianjin.
    Zhao B; Wu J
    Int J Health Policy Manag; 2023; 12():7724. PubMed ID: 38618801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "4+7" city drug volume-based purchasing and using pilot program in China and its impact.
    Tang M; He J; Chen M; Cong L; Xu Y; Yang Y; Hou Z; Song P; Jin C
    Drug Discov Ther; 2019; 13(6):365-369. PubMed ID: 31956236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of National Centralised Drug Procurement policy on the use of policy-related original and generic drugs in China.
    Yang Y; Hu R; Geng X; Mao L; Wen X; Wang Z; Hao S; Cui D; Mao Z
    Int J Health Plann Manage; 2022 May; 37(3):1650-1662. PubMed ID: 35132676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impacts of Chinese drug volume-based procurement policy on the use of policy-related antibiotic drugs in Shenzhen, 2018-2019: an interrupted time-series analysis.
    Yang Y; Chen L; Ke X; Mao Z; Zheng B
    BMC Health Serv Res; 2021 Jul; 21(1):668. PubMed ID: 34238290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing Characteristics of Pharmaceutical Prices in China Under Centralized Procurement Policy: A Multi-Intervention Interrupted Time Series.
    Long H; Yang Y; Geng X; Mao Z; Mao Z
    Front Pharmacol; 2022; 13():944540. PubMed ID: 35910351
    [No Abstract]   [Full Text] [Related]  

  • 9. Impacts of national volume-based drug procurement policy on the utilization and costs of antihypertensive drugs in a Chinese medicine hospital: an interrupted time series analysis of 5138 patients.
    Shang L; Cheng Y; Zhou J; Bao Y; Kong D; Huang R; Chen Y; Wang H; Gu N; Ma A
    Front Pharmacol; 2024; 15():1302154. PubMed ID: 38389928
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of the National Centralized Drug Procurement Policy (4 + 7 policy) on the drug expenditures of patients treated in outpatient and emergency departments in a large tertiary level-A hospital in China: A single centre, interrupted time series.
    Lan T; Guan L; Pang X; Li X; Yu Q
    J Clin Pharm Ther; 2022 Jan; 47(1):104-111. PubMed ID: 34668203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The change of drug utilization in China's public healthcare institutions under the "4 + 7" centralized drug procurement policy: Evidence from a natural experiment in China.
    Lu J; Long H; Shen Y; Wang J; Geng X; Yang Y; Mao Z; Li J
    Front Pharmacol; 2022; 13():923209. PubMed ID: 36081942
    [No Abstract]   [Full Text] [Related]  

  • 12. The vacated space of volume/price of the drugs centralized procurement with quantity in secondary and above public hospitals of China.
    Wang J; Zhang S; Wang C; Li J; Wang R; Zhu L
    BMC Health Serv Res; 2024 Jun; 24(1):771. PubMed ID: 38951849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quasi-experimental study of the volume-based procurement (VBP) effect on antiviral medications of hepatitis B virus in China.
    Wen X; Xu L; Chen X; Wu R; Luo J; Wan Y; Mao Z
    Front Pharmacol; 2023; 14():984794. PubMed ID: 37731741
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of Chinese National Centralized Drug Procurement on the price of policy-related drugs: an interrupted time series analysis.
    Wang N; Yang Y; Xu L; Mao Z; Cui D
    BMC Public Health; 2021 Oct; 21(1):1883. PubMed ID: 34663282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies.
    Acosta A; Ciapponi A; Aaserud M; Vietto V; Austvoll-Dahlgren A; Kösters JP; Vacca C; Machado M; Diaz Ayala DH; Oxman AD
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD005979. PubMed ID: 25318966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impacts of the zero mark-up drug policy on hospitalization expenses of COPD inpatients in Sichuan province, western China: an interrupted time series analysis.
    Wang J; Li P; Wen J
    BMC Health Serv Res; 2020 Jun; 20(1):519. PubMed ID: 32513170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impacts of the "4+7" pilot policy on the volume, expenditures, and daily cost of Serotonin-Specific Reuptake Inhibitors (SSRIs) antidepressants: A quasi-experimental study.
    Wen X; Wang Z; Xu L; Luo J; Geng X; Chen X; Yang Y; Cui D; Mao Z
    Front Pharmacol; 2022; 13():829660. PubMed ID: 36060003
    [No Abstract]   [Full Text] [Related]  

  • 18. Trends in accessibility of negotiated targeted anti-cancer medicines in Nanjing, China: An interrupted time series analysis.
    Liu Y; Yi H; Fang K; Bao Y; Li X
    Front Public Health; 2022; 10():942638. PubMed ID: 35937254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Government Price Regulation on the Price, Volume and Spending of Antibiotics in China: A Controlled Interrupted Time Series Study.
    Wushouer H; Luo Z; Guan X; Shi L
    Int J Health Policy Manag; 2022 Feb; 11(2):218-223. PubMed ID: 32702801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicaid prescription limits: policy trends and comparative impact on utilization.
    Lieberman DA; Polinski JM; Choudhry NK; Avorn J; Fischer MA
    BMC Health Serv Res; 2016 Jan; 16():15. PubMed ID: 26772962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.